Etermis

Etermis

THE DERMAL FILLER FOR EVERYONE

  • The range consists of three monophasic, cohesive, hyaluronic acid (HA) fillers combined with mannitol.
  • Mannitol is an antioxidant that acts as a free-radical scavenger to minimise degradation of HA when the filler is injected.
  • ETERMIS product range offers what you need to achieve beautiful results in the treatment of fine lines, moderate and severe wrinkles.
  • Description
  • Treatment Areas
  • Produce Profile

Product Description

Etermis Pack ShotQUALITY STANDARDS OF GERMAN ENGINEERING

Excellent safety profile

ETERMIS product range meets high expectations:

  • good tolerability
  • low rate of adverse events

High-tech meets aesthetics

ETERMIS fillers are designed for:

  • natural looks and smooth transitions
  • long-lasting duration of aesthetic effect
  • low extrusion force

Broad filler range. High performance.

ETERMIS product range is ideal for the aesthetic treatment of

  • delicate areas and lips, e.g. increase of lip volume
  • fine lines and moderate wrinkles
  • deep and severe folds

 

Etermis Treatment Areas

Etermis 2ETERMIS 2 – when it comes to delicate areas

Your reliable partner for mild and superficial wrinkles

  • perioral lines
  • lips (contours)

Injection protocol:
Inject into the upper dermis with an angle of approximately 15 degrees between needle and skin surface.¹


Etermis 3ETERMIS 3 – create impressing aesthetic results

The art of effective treatments – for moderate wrinkles and lip enhancement

  • nasolabial folds
  • marionette lines
  • lip enhancement

Injection protocol:
Inject into the mid to deep dermis with an angle of approximately 30–35 degrees between needle and skin surface.¹


Etermis 4ETERMIS 4 – strong but discreet results

Deep and severe wrinkles:

  • nasolabial folds
  • marionette lines
  • lip enhancement

Injection protocol:
Inject into the mid and deep dermis with an angle of approximately 30–35 degrees between needle and skin surface.¹

1. See Merz Aesthetics Guidelines for injection technique.
Indications for Etermis 2, Etermis 3 and Etermis 4 are subject to the Instructions for Use (last r evision 03/2016)